US 11,884,686 B2Granted

Chelate compounds

AssigneeGe Healthcare Limited

InventorsAndreas Richard Meijer, Mikkel Jacob Thaning, Brian Christopher Bales, Michael James Rishel

Life of this patent

Estimating the term…

Abstract

The invention provides compounds suitable for use as contrast agents in magnetic resonance imaging (MRI). The compounds of the present invention are manganese (II) complexes having advantageous properties as compared with similar known compounds.

Claims6

Dependent claims

A compound represented by:

Dependencies are inferred from the claim text.

Facts

Application: 16/311,564Filed 20 Jun 2017
Priority: GB 161073820 Jun 2016
Published: US 2019/0233450 A11 Aug 2019
Granted: 30 Jan 2024
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

C07F 13/005
Compounds containing elements of Groups 7 or 17 of the Periodic Table: compounds without a metal-carbon linkage
A61K 49/106
The carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals: the complex-forming compound being…
C07D 471/08
In which the condensed system contains two hetero rings: bridged systems
C07F
Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen

Family

US 2019/0233450 A1Pre-grant publication · published 1 Aug 2019
US 11,884,686 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results